Skip to main content
. Author manuscript; available in PMC: 2013 Apr 2.
Published in final edited form as: Arch Gen Psychiatry. 2012 Sep;69(9):973–981. doi: 10.1001/archgenpsychiatry.2012.1a

Figure 2.

Figure 2

Kaplan-Meier survival evaluating treatment dropout and relapse.

NI+OP indicates 1000-mg naltrexone implantandoral placebo (n=102);

PI+NO, placebo implant and 50-mg oral naltrexone hydrochloride (n=102);

PI+OP, placebo implant and oral placebo (n=102).